Follow-On Biologics Deal Gives Brands 12 Years Of Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
A senate markup is scheduled for June 27 on legislation to create abbreviated BLA approval pathway.
You may also be interested in...
Generic Biologics Bill Still Has Good Chance For Enactment This Year – Waxman, Pallone
Key House legislators assure generics industry that they remain committed to generic biologics legislation, though PDUFA will move ahead without it.
Generic Biologics Bill Still Has Good Chance For Enactment This Year – Waxman, Pallone
Key House legislators assure generics industry that they remain committed to generic biologics legislation, though PDUFA will move ahead without it.
Follow-On Biologics Bill Clears Senate Cmte. With Stronger Language On Exclusivity Cap
Generic firms remain concerned that innovators would be able to "evergreen" their products through minor changes.